BVMF
PGMN3
Market cap732mUSD
Oct 16, Last price
5.13BRL
1D
5.12%
1Q
49.13%
IPO
-50.67%
Name
Empreendimentos Pague Menos SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Empreendimentos Pague Menos S.A. operates a prominent pharmacy chain across Brazil, offering a comprehensive array of health and wellness products. Their extensive inventory includes a wide variety of medications spanning numerous therapeutic categories such as pain relief, allergy treatment, digestive health, diabetes management, and vitamins. Beyond pharmaceuticals, the company provides a vast selection of personal care and beauty products, dermo-cosmetics, and specialized items for mothers and babies. They also stock general merchandise, including toys, clothing, food, beverages, and various household essentials. Established in 1981 and headquartered in Fortaleza, Brazil, Pague Menos manages a substantial retail network of 1,105 stores throughout the country.
Key people
Josue Ubiranilson Alves
Deputy Chief Executive Officer, Member of the Executive Board, Director
Edson de Arruda Camara
Chief Operating Officer, Member of the Executive Board
Carlos Henrique Alves de Queiros
Chief Expansion and New Business Officer, Member of the Executive Board · since 2010
Patriciana Maria de Queiros Rodrigues
Chief Commercial Officer, Member of the Executive Board · since 2004
Mario Henrique Alves de Queiros
Chief Planning and Investor Relations Officer, Member of the Executive Board · since 2011
Armando Lima Caminha
Chief Financial Officer, Member of the Executive Board
Rosilandia Maria Alves Dias
Director
Director
Geraldo Luciano Mattos
Director
Joao Barbosa Pinheiro
Independent Director
Legal address
Rua Senador Pompeu, 1520
Centro
Fortaleza, CE 60025-002
BR
Centro
Fortaleza, CE 60025-002
BR
Headquarters
Rua Senador Pompeu, 1520
Fortaleza, CE 60025-002
BR
Fortaleza, CE 60025-002
BR
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||